Subtype
Brain Neoplasm
CI-CAN-00002030Explore in graph →
Non-malignant511 active trials34 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002030Explore in graph →
Clinical trials
2,117 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07085325 | CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation | recruiting | — | 184 | St. Jude Children's Research HospitalOTHER | 1 | Jul 6, 2026 | clinicaltrials |
| NCT07685301 | Development and Validation of an AI Foundation Model for CNS Tumor Classification(CNS-AIClass) | not yet recruiting | — | 20,000 | Huashan HospitalOTHER | 0 | Jul 6, 2026 |
| clinicaltrials |
| NCT02390518 | Stereotactic Radiosurgery Dose Escalation for Brain Metastases | recruiting | Phase 1 | 86 | University of UtahOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT03208387 | Understanding the Late Effects of Surviving a Pediatric Brain Tumor | active not recruiting | — | 42 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT07118176 | Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers | active not recruiting | Phase 1 | 30 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT04195555 | Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) | active not recruiting | Phase 2 | 3 | National Cancer Institute (NCI)NIH | 3 | Jul 1, 2026 | clinicaltrials |
| NCT06388733 | A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma | active not recruiting | Phase 3 | 450 | Ivy Brain Tumor CenterOTHER | 11 | Jul 1, 2026 | clinicaltrials |
| NCT07210632 | Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG) | recruiting | Early Phase 1 | 38 | Eben RosenthalOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT03223922 | Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases | active not recruiting | N/A | 40 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT07316101 | Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery | recruiting | N/A | 20 | West China HospitalOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT07493447 | Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures | recruiting | Early Phase 1 | 30 | Eben RosenthalOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT07670455 | Brain Radiotherapy Imaging for High-grade Glioma Using Hypoxia Targeting Through Oxygen-Enhanced Response(BRIGHTER) | not yet recruiting | N/A | 25 | The Leeds Teaching Hospitals NHS TrustOTHER | 0 | Jun 30, 2026 | clinicaltrials |
| NCT07675070 | Safety and Effectiveness Evaluation of Temozolomide (Amitzo, NanoAlvand) in Patients With Grade III and IV Glioma Tumors | recruiting | — | 100 | NanoAlvandINDUSTRY | 1 | Jun 30, 2026 | clinicaltrials |
| NCT03510208 | Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery | recruiting | Phase 1 / Phase 2 | 46 | Stanford UniversityOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT05658731 | Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients(CogRT) | recruiting | N/A | 338 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT06333899 | Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion | recruiting | Early Phase 1 | 15 | Nationwide Children's HospitalOTHER | 6 | Jun 29, 2026 | clinicaltrials |
| NCT05009992 | Combination Therapy for the Treatment of Diffuse Midline Gliomas(PNOC022) | recruiting | Phase 2 | 360 | University of California, San FranciscoOTHER | 6 | Jun 26, 2026 | clinicaltrials |
| NCT06905587 | Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue(EMBRAIN) | recruiting | Phase 3 | 50 | Odense University HospitalOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT03175432 | Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases | active not recruiting | Phase 2 | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT05435859 | Functional Organization of the Superior Temporal Gyrus for Speech Perception | enrolling by invitation | N/A | 60 | University of California, San FranciscoOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT06962215 | The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery (IPSIMANON)(IPSIMANON) | recruiting | N/A | 250 | University Hospital, BrestOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT07460232 | FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease | recruiting | Early Phase 1 | 50 | Mayo ClinicOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT07650994 | Movie-Watching Functional MRI for Mapping Brain Function in Neurosurgical Patients | not yet recruiting | N/A | 90 | Brigham and Women's HospitalOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT03299309 | PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma(PRiME) | active not recruiting | Phase 1 | 30 | Daniel LandiOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT07657403 | CONNEctome-guided Navigation for Eloquent-area Tumor Surgery Trial(CONNECT Trail) | recruiting | N/A | 200 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT00840047 | Methionine PET/CT Studies In Patients With Cancer | active not recruiting | Phase 2 | 503 | St. Jude Children's Research HospitalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT02256137 | A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer | active not recruiting | — | 1,564 | St. Jude Children's Research HospitalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | active not recruiting | Phase 2 | 798 | National Cancer Institute (NCI)NIH | 2 | Jun 17, 2026 | clinicaltrials |
| NCT03050268 | Familial Investigations of Childhood Cancer Predisposition(SJFAMILY) | recruiting | — | 1,500 | St. Jude Children's Research HospitalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT03086421 | Social Emotional Development in Young Children With Cancer | active not recruiting | — | 119 | St. Jude Children's Research HospitalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT03213704 | Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) | active not recruiting | Phase 2 | 9 | National Cancer Institute (NCI)NIH | 2 | Jun 17, 2026 | clinicaltrials |
| NCT05947045 | Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors | recruiting | N/A | 45 | St. Jude Children's Research HospitalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT06193759 | Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)(IMPACT) | recruiting | Phase 1 | 12 | Children's National Research InstituteOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT06104488 | A Study of Avutometinib for People With Solid Tumor Cancers | active not recruiting | Phase 1 | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT06666712 | Chronic CED of TPT for Recurrent Malignant Glioma(TPT CED rHGG) | recruiting | Phase 1 | 6 | Jeffrey N. BruceOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT06914479 | Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors | recruiting | Phase 1 | 11 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT07570485 | Feasibility Assessment of Adapted Physical Activity in Patients Treated for a Brain Tumor(APATC) | not yet recruiting | N/A | 90 | Center Eugene MarquisOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT07642856 | Individualized Neuro-Modulation Paired With Cerebellar Therapy(IMPACT) | recruiting | N/A | 30 | Hugo W. Moser Research Institute at Kennedy Krieger, Inc.OTHER | 1 | Jun 11, 2026 | clinicaltrials |
| NCT03224767 | Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma | active not recruiting | Phase 2 | 24 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT05521984 | Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) | recruiting | Phase 1 | 20 | Washington University School of MedicineOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT06788886 | Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases | recruiting | N/A | 147 | Mayo ClinicOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT03550391 | Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases | recruiting | Phase 3 | 206 | Canadian Cancer Trials GroupNETWORK | 2 | Jun 9, 2026 | clinicaltrials |
| NCT05393492 | Regulating Emotions and Behaviors After Brain Injury(GREMO-LCA) | recruiting | N/A | 77 | University Hospital, Strasbourg, FranceOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT05864794 | Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer(VULCAN) | recruiting | N/A | 100 | University Medical Center GroningenOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT07274397 | Assessment of Early Post-operative Nuclear Imaging in Neurosurgery: a Safety and Feasibility Study in Patients Operated for Glioblastoma(EARLYBRAINPET) | recruiting | N/A | 15 | Beta Emitting Accurate Monitored SystemsINDUSTRY | 1 | Jun 8, 2026 | clinicaltrials |
| NCT07632092 | Early [18F]-FDG PET Dynamic Analysis in Brain Metastases After Radiotherapy.(DYNFDGTEP) | recruiting | — | 50 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Jun 8, 2026 | clinicaltrials |
| NCT04074096 | Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis(BEPCOME-MB) | active not recruiting | Phase 2 | 10 | UNICANCEROTHER | 1 | Jun 5, 2026 | clinicaltrials |
| NCT07628647 | Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being(LWBC) | not yet recruiting | N/A | 64 | University of Colorado, DenverOTHER | 1 | Jun 5, 2026 | clinicaltrials |
| NCT07629089 | VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations(VALIENT) | not yet recruiting | Phase 1 | 24 | Megan ManticaOTHER | 1 | Jun 5, 2026 | clinicaltrials |
| NCT02649582 | Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients(ADDIT-GLIO) | active not recruiting | Phase 1 / Phase 2 | 20 | University Hospital, AntwerpOTHER | 1 | Jun 4, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jul 6, 2026source: clinicaltrials